+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Digital Biomarkers Market by Component (Hardware, Software), Biomarker Type (Active, Passive), Functionality, Therapeutic Area, Application, End User - Global Forecast 2025-2030- Product Image
Digital Biomarkers Market by Component (Hardware, Software), Biomarker Type (Active, Passive), Functionality, Therapeutic Area, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Digital Biomarkers Market by Component (Hardware, Software), Biomarker Type (Active, Passive), Functionality, Therapeutic Area, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924667
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Digital Biomarkers Market grew from USD 2.13 billion in 2024 to USD 2.36 billion in 2025. It is expected to continue growing at a CAGR of 10.80%, reaching USD 3.96 billion by 2030.

Establishing the Foundational Context for Digital Biomarkers in Healthcare Research Clinical Trials and Patient Management

In an era defined by rapid technological progress and evolving patient demands, digital biomarkers have emerged as a transformative force reshaping clinical research and personalized healthcare. These objective, quantifiable physiological and behavioral data collected through advanced sensors and software applications represent a paradigm shift from traditional assessment methods. The integration of digital biomarkers promises to enhance diagnostic accuracy, streamline drug development pathways, and foster proactive patient monitoring.

Our analysis delves into the convergence of hardware innovations, software intelligence, and regulatory momentum driving this ecosystem forward. By contextualizing the key enablers-from implantable devices to wearable sensors and sophisticated analytics platforms-we frame the foundational landscape underpinning current market dynamics. This introduction establishes the critical context for stakeholders seeking to navigate the complex interplay of technological capabilities, clinical validation imperatives, and evolving patient expectations.

Exploring the Transformative Technological Regulatory and Collaboration Shifts Reshaping the Digital Biomarkers Ecosystem

Over the past few years, the digital biomarkers landscape has undergone profound shifts driven by breakthroughs in sensor miniaturization, cloud-based analytics, and artificial intelligence. As hardware components have become increasingly compact and energy-efficient, continuous monitoring of physiological signals has transitioned from sporadic clinical snapshots to real-world, longitudinal data streams. Simultaneously, machine learning algorithms have evolved to extract meaningful patterns from these vast datasets, facilitating early detection of disease progression and treatment response.

Moreover, regulatory bodies have started crafting clear guidelines that balance innovation with patient safety, fostering greater confidence among industry stakeholders. Public-private collaborations and consortium-driven standardization initiatives have also accelerated interoperability and data harmonization efforts. As stakeholders adapt to these transformative forces, they are positioned to harness digital biomarkers not merely as ancillary tools but as central pillars in evidence generation and patient-centric care models.

Assessing the Far Reaching Consequences of United States Tariff Adjustments on the Digital Biomarkers Supply Chain in 2025

The introduction of new United States tariffs in 2025 has imposed meaningful cost pressures on components integral to the digital biomarkers supply chain, particularly on advanced sensors and semiconductor modules produced overseas. Device manufacturers have had to reassess sourcing strategies and explore alternate suppliers to mitigate margin erosion. In parallel, research institutions and clinical trial sponsors are adjusting budget allocations to accommodate higher device procurement costs, which in turn influences trial design and enrollment budgets.

Despite these headwinds, many organizations have responded with innovative procurement partnerships and regional manufacturing initiatives aimed at localizing production. These adaptations reduce reliance on tariff-impacted imports while preserving the pace of development. As a result, the industry is witnessing a recalibration of supply chain priorities, balancing cost containment with the imperative to maintain stringent quality and performance standards for digital biomarker solutions.

Unveiling In Depth Segmentation Perspectives That Illuminate Component Biomarker Type Functionality Application End User and Therapeutic Area Opportunities

Digital biomarker solutions are best understood through multiple analytical lenses that reveal distinct opportunities and challenges. When viewed through the component perspective, hardware encompasses implantable devices, sensors, and wearables while software layers drive data interpretation and integration. Within hardware, implantables enable continuous internal monitoring, sensors support detailed physiological readings, and wearables such as fitness bands and smartwatches deliver consumer-friendly tracking. Each category has unique technical requirements and validation pathways that influence development timelines and regulatory engagement.

Examining biomarker types uncovers a dichotomy between active approaches requiring deliberate patient input and passive methods that capture data unobtrusively during routine activities. Functionality further segments insights into continuous monitoring for real-time vigilance, event-driven triggers for acute episodes, and periodic assessments suited to scheduled clinical visits. Applications range from disease diagnostics that enable early detection to drug development platforms that optimize dosing strategies and patient stratification, as well as patient monitoring systems that support remote care pathways.

End users span from academic and research institutes fostering foundational innovation to biotechnology firms translating discoveries into products, hospitals and clinics integrating digital endpoints into care protocols, and pharmaceutical companies leveraging biomarkers for clinical decision support. Finally, therapeutic area distinctions highlight cardiology applications such as arrhythmia detection and heart failure management, endocrinology use cases in diabetes mellitus and thyroid disorders, neurology efforts targeting Alzheimer’s and Parkinson’s diseases, oncology research addressing breast and prostate cancers, and pulmonology interventions for respiratory conditions. This multifaceted segmentation framework offers a comprehensive view of how diverse market segments converge to shape the digital biomarkers domain.

Analyzing How Regional Dynamics in Americas Europe Middle East Africa and Asia Pacific Shape Digital Biomarkers Adoption and Growth

Geographically, the Americas region commands attention through robust investment in research infrastructure, a dense network of clinical trial sites, and favorable reimbursement pathways for novel digital health solutions. Meanwhile, Europe Middle East and Africa benefit from harmonized regulatory frameworks across the EU, growing public health mandates for remote monitoring, and emerging digital health hubs in the Gulf and African markets. These regions are driving standardization efforts and forging cross-border research collaborations.

In the Asia-Pacific arena, rapid adoption of mobile health technologies, expanding healthcare coverage, and government incentives for local innovation present unique drivers of digital biomarker uptake. Regional manufacturers are scaling production capabilities, while domestic players collaborate with global technology providers. As these three major markets evolve, differences in healthcare delivery models, data privacy regulations, and reimbursement structures define tailored strategies for market entry, partnership development, and long-term growth.

Profiling the Competitive Ecosystem Where Device Innovators Software Developers Clinical Research Partners and Strategic Alliances Drive Digital Biomarker Advancements

Leading players in the digital biomarkers field encompass an ecosystem that integrates device creators, software innovators, clinical research service providers, and strategic partners. Device manufacturers compete on sensor accuracy, battery life, and user comfort, while software firms differentiate through algorithm sophistication, scalability, and regulatory readiness. Clinical research organizations are embedding digital endpoints into trial protocols to enhance patient engagement and remote monitoring capabilities.

Strategic alliances between technology vendors and pharmaceutical developers are producing co-developed solutions that align biomarker insights with therapeutic objectives. Partnerships with academic institutions and healthcare systems further accelerate clinical validation and real-world evidence generation. Collectively, these dynamics underscore an ecosystem where collaboration and specialization converge, driving competitive advantage and fostering a new wave of digital biomarker-enabled products and services.

Implementing Strategic Cross Functional Collaboration Modular Development and Proactive Regulatory Engagement to Accelerate Digital Biomarker Deployment

Industry leaders should prioritize the establishment of cross-functional teams that span engineering, clinical science, and regulatory affairs to streamline development cycles and expedite market entry. By embedding data scientists alongside clinical experts from project inception, organizations can design biomarker studies that align with both analytical requirements and therapeutic endpoints. Furthermore, pursuing modular technology platforms allows for iterative enhancement and rapid deployment across multiple indications.

To counter tariff-induced cost pressures, stakeholders must explore joint procurement agreements and regional manufacturing partnerships that reduce supply chain risk. Additionally, engaging proactively with regulatory bodies to shape guidance on digital endpoint validation and data privacy will strengthen market preparedness. Emphasizing real-world evidence generation and leveraging post-market surveillance data can bolster payer acceptance and support value-based reimbursement models.

Combining Qualitative Interviews Detailed Secondary Analysis and Expert Workshops to Deliver Robust Digital Biomarker Market Insights

This research integrates primary and secondary methodologies to capture a holistic view of the digital biomarkers landscape. Primary data collection involved in-depth interviews with sensor designers, software engineers, clinical trial leaders, and regulatory specialists to surface current challenges and future priorities. These qualitative insights were complemented by exhaustive secondary analysis of peer-reviewed journals, white papers, and industry reports to corroborate emerging technology trends and regulatory shifts.

A rigorous framework guided data triangulation, ensuring consistency across sources and fostering robust conclusions. Market participants were profiled based on technological capabilities, partnership footprints, and clinical validation track records. Segmentation structures were validated through expert workshops that examined component hierarchies, application domains, and therapeutic focus areas. This mixed-method approach underpins the credibility of our findings and supports actionable insights for stakeholders.

Synthesizing How Innovation Collaboration and Strategic Alignment Will Drive the Next Generation of Digital Biomarker Applications

Digital biomarkers stand at the crossroads of innovation and clinical impact, offering unprecedented opportunities to enhance patient care, streamline drug development, and support value-based healthcare models. The interplay of hardware miniaturization, advanced analytics, and regulatory evolution has established a dynamic ecosystem where collaboration accelerates progress. As stakeholders adapt to cost pressures and regional complexities, a strategic focus on modular platforms, cross-disciplinary teams, and real-world evidence will determine success trajectories.

Ultimately, the sustained advancement of digital biomarkers hinges on collective efforts to validate clinical utility, ensure data integrity, and navigate regulatory pathways. Organizations that align technological innovation with clinical and commercial imperatives will be well positioned to lead the next generation of personalized medicine and patient-centric research.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Component
    • Hardware
      • Implantables
      • Sensors
      • Wearables
        • Fitness Bands
        • Smartwatches
    • Software
  • Biomarker Type
    • Active
    • Passive
  • Functionality
    • Continuous
    • Event-Driven
    • Periodic
  • Therapeutic Area
    • Cardiology
      • Arrhythmia
      • Heart Failure
    • Endocrinology
      • Diabetes Mellitus
      • Thyroid Disorders
    • Neurology
      • Alzheimer's Disease
      • Parkinson's Disease
    • Oncology
      • Breast Cancer
      • Prostate Cancer
    • Pulmonology
  • Application
    • Disease Diagnostics
    • Drug Development
    • Patient Monitoring
  • End User
    • Academic & Research Institutes
    • Biotechnology Firms
    • Hospitals & Clinics
    • Pharmaceutical Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • ActiGraph, LLC
  • Adherium Limited
  • Altoida, Inc.
  • Amgen Inc.
  • Aural Analytics, Inc. by Linus Health, Inc.
  • Biofourmis Pte. Ltd.
  • Biogen Inc.
  • Brainomix Limited
  • Eli Lilly and Company
  • Empatica Inc.
  • F. Hoffmann-La Roche Ltd.
  • Feel Therapeutics Inc.
  • GERO PTE. LTD.
  • Huma Therapeutics Limited
  • ICON PLC
  • IXICO PLC
  • Koneksa Health Inc.
  • Medable Inc.
  • Owkin, Inc.
  • Sonde Health, Inc
  • Teva Pharmaceutical Industries Ltd.
  • Verily Life Sciences, LLC
  • VivoSense, Inc
  • Chugai Pharmaceutical Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence to enhance digital biomarker accuracy and predictive capabilities
5.2. Development of novel digital biomarkers for early detection of neurodegenerative diseases
5.3. Surging collaborations and partnerships to advance digital biomarker innovation
5.4. Development of digital biomarkers for mental health for objective assessment and treatment response
5.5. Expanding use of digital biomarkers in remote patient monitoring to improve chronic disease management
5.6. Growing regulatory frameworks accelerating approval and adoption of digital biomarker technologies
5.7. Implementation of blockchain technology for secure and transparent digital biomarker data management
5.8. Rising adoption of digital biomarkers in personalized medicine for tailored treatment plans
5.9. Advancements in multi-modal digital biomarkers combining physiological and behavioral data
5.10. Expansion of wearable devices enabling continuous real-time monitoring of health metrics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Digital Biomarkers Market, by Component
8.1. Introduction
8.2. Hardware
8.2.1. Implantables
8.2.2. Sensors
8.2.3. Wearables
8.2.3.1. Fitness Bands
8.2.3.2. Smartwatches
8.3. Software
9. Digital Biomarkers Market, by Biomarker Type
9.1. Introduction
9.2. Active
9.3. Passive
10. Digital Biomarkers Market, by Functionality
10.1. Introduction
10.2. Continuous
10.3. Event-Driven
10.4. Periodic
11. Digital Biomarkers Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiology
11.2.1. Arrhythmia
11.2.2. Heart Failure
11.3. Endocrinology
11.3.1. Diabetes Mellitus
11.3.2. Thyroid Disorders
11.4. Neurology
11.4.1. Alzheimer's Disease
11.4.2. Parkinson's Disease
11.5. Oncology
11.5.1. Breast Cancer
11.5.2. Prostate Cancer
11.6. Pulmonology
12. Digital Biomarkers Market, by Application
12.1. Introduction
12.2. Disease Diagnostics
12.3. Drug Development
12.4. Patient Monitoring
13. Digital Biomarkers Market, by End User
13.1. Introduction
13.2. Academic & Research Institutes
13.3. Biotechnology Firms
13.4. Hospitals & Clinics
13.5. Pharmaceutical Companies
14. Americas Digital Biomarkers Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Digital Biomarkers Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Digital Biomarkers Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. ActiGraph, LLC
17.3.2. Adherium Limited
17.3.3. Altoida, Inc.
17.3.4. Amgen Inc.
17.3.5. Aural Analytics, Inc. by Linus Health, Inc.
17.3.6. Biofourmis Pte. Ltd.
17.3.7. Biogen Inc.
17.3.8. Brainomix Limited
17.3.9. Eli Lilly and Company
17.3.10. Empatica Inc.
17.3.11. F. Hoffmann-La Roche Ltd.
17.3.12. Feel Therapeutics Inc.
17.3.13. GERO PTE. LTD.
17.3.14. Huma Therapeutics Limited
17.3.15. ICON PLC
17.3.16. IXICO PLC
17.3.17. Koneksa Health Inc.
17.3.18. Medable Inc.
17.3.19. Owkin, Inc.
17.3.20. Sonde Health, Inc
17.3.21. Teva Pharmaceutical Industries Ltd.
17.3.22. Verily Life Sciences, LLC
17.3.23. VivoSense, Inc
17.3.24. Chugai Pharmaceutical Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DIGITAL BIOMARKERS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DIGITAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DIGITAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. DIGITAL BIOMARKERS MARKET: RESEARCHAI
FIGURE 28. DIGITAL BIOMARKERS MARKET: RESEARCHSTATISTICS
FIGURE 29. DIGITAL BIOMARKERS MARKET: RESEARCHCONTACTS
FIGURE 30. DIGITAL BIOMARKERS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DIGITAL BIOMARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY IMPLANTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY IMPLANTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FITNESS BANDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FITNESS BANDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SMARTWATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SMARTWATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ACTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ACTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PASSIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PASSIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY EVENT-DRIVEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY EVENT-DRIVEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PERIODIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PERIODIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THYROID DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY THYROID DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PULMONOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 150. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 151. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 152. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 153. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 154. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 155. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 158. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 159. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 160. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 161. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 162. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 163. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 164. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 165. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 166. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 167. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 168. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 169. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 174. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 175. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 178. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 179. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 184. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 185. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 190. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 191. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 192. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 193. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 296. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 297. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 298. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 299. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 300. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 301. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 302. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 303. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 304. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 305. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 306. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 307. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 308. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 309. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 310. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 311. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 312. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 313. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 314. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 315. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 320. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 321. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 322. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 323. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2018-2024 (USD MILLION)
TABLE 324. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLES, 2025-2030 (USD MILLION)
TABLE 325. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 326. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 327. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 328. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 329. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 330. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 331. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 332. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 333. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 334. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 335. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 336. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 337. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 338. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 339. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 340. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 341. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 345. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 346. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 347. RUSS

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Digital Biomarkers market report include:
  • ActiGraph, LLC
  • Adherium Limited
  • Altoida, Inc.
  • Amgen Inc.
  • Aural Analytics, Inc. by Linus Health, Inc.
  • Biofourmis Pte. Ltd.
  • Biogen Inc.
  • Brainomix Limited
  • Eli Lilly and Company
  • Empatica Inc.
  • F. Hoffmann-La Roche Ltd.
  • Feel Therapeutics Inc.
  • GERO PTE. LTD.
  • Huma Therapeutics Limited
  • ICON PLC
  • IXICO PLC
  • Koneksa Health Inc.
  • Medable Inc.
  • Owkin, Inc.
  • Sonde Health, Inc
  • Teva Pharmaceutical Industries Ltd.
  • Verily Life Sciences, LLC
  • VivoSense, Inc
  • Chugai Pharmaceutical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.36 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.96 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report by Type (Wearables, Mobile-Based Applications, Sensors), Clinical Practice (Diagnostic, Monitoring, Predictive & Prognostic), End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report by Type (Wearables, Mobile-Based Applications, Sensors), Clinical Practice (Diagnostic, Monitoring, Predictive & Prognostic), End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Digital Biomarkers: Global Markets - Product Image

Digital Biomarkers: Global Markets

  • Report
  • 129 Pages
  • Global
From
Psychiatric Digital Biomarkers - Global Strategic Business Report - Product Image

Psychiatric Digital Biomarkers - Global Strategic Business Report

  • Report
  • 386 Pages
  • Global
From
Digital Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Digital Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 170 Pages
  • Global
From
Digital Biomarkers Market Report 2025 - Product Image

Digital Biomarkers Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Digital Biomarker Market

The Digital Biomarker market is a subset of the Internet and E-Commerce industry, focusing on the development and use of digital biomarkers. Digital biomarkers are digital tools that measure and track health-related data, such as physical activity, sleep, and nutrition. This data can be used to monitor and improve health outcomes, as well as to develop personalized treatments. Digital biomarkers are increasingly being used in clinical trials, as well as in the development of digital therapeutics. The Digital Biomarker market is growing rapidly, driven by the increasing demand for personalized healthcare solutions. This market is expected to continue to grow as more healthcare providers and pharmaceutical companies adopt digital biomarkers. Some companies in the Digital Biomarker market include Apple, Fitbit, Google, Microsoft, and Philips. These companies are developing digital biomarkers for a variety of applications, including health monitoring, disease management, and clinical trials. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.